UT Health Northeast in Tyler, TX, joins MD Anderson Network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UT Health Northeast in Tyler, TX, and MD Anderson Cancer Center announced a partnership to provide greater access to the most advanced cancer care available for adult patients in northeast Texas and the surrounding region.

Through the partnership, UT Health Northeast’s Cancer Treatment and Prevention Center joins MD Anderson Cancer Network, an international collaboration of hospitals and health systems that share and contribute to MD Anderson’s mission to end cancer. The center in Tyler will be known as UT Health Northeast MD Anderson Cancer Center when it officially launches in 2017.

UT Health Northeast’s cancer program will be clinically and operationally integrated with MD Anderson Cancer Center, joining only six other healthcare institutions across the U.S. and three facilities in Brazil, Spain and Turkey. Enhanced local access to MD Anderson’s multidisciplinary care, treatment innovations, standards of care and clinical trials will be hallmarks of the partnership.

The two organizations will join forces in the recruitment of all future program physicians and allied health staff. A national search to hire a medical director to lead the new program is planned.

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login